Allegheny County’s longest cold case for an unidentified victim has been solved using DNA technology. On Wednesday, the Allegheny County Medical Examiner’s Office announced the body of an unknown ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Researchers from Samsung Electronic Co. Ltd. have created a tiny artificial intelligence model that punches far above its weight on certain kinds of “reasoning” tasks, challenging the industry’s ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

KNOXVILLE, Tenn. (WVLT) - When Tennessee entered its first of two open dates last season, the Vols were set to face Arkansas on the road, unbeaten, and ranked in the top ten nationally. Following the ...

Implement Longest Common Subsequence (LCS) algorithm to find the length and LCS for DNA sequences. Also finding Longest Repeating Subsequence(LRS) to match patterns.

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

We recently published 10 Resilient Stocks Defying Market Sentiment. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Monday’s biggest gainers. Recursion Pharmaceuticals grew its share prices ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

Courts across the country are facing a deluge of filings from attorneys and litigants that back their arguments with nonexistent research hallucinated by generative artificial intelligence, prompting ...